EmersonY.ChenMD

Oncology • Portland, OR

Physician

Join to view full profile

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chen's full profile

Already have an account?

Office
3181 SW Sam Jackson Park Rd
# Mail
Portland, OR 97239
Phone+1 503-494-4335

Education & Training

University of Pennsylvania Health SystemResidency, Internal Medicine, 2013 - 2016
University of Miami Leonard M. Miller School of MedicineClass of 2013

Certifications & Licensure

WA State Medical License 2024 - 2026
ID State Medical License 2021 - 2025
OR State Medical License 2017 - 2025
PA State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Liver-First Resection in Patients With Synchronous Colorectal Liver Metastases Is Associated With Inferior Recurrence-Free Survival: Reconsidering the Importance of th...
Thomas L Sutton, Ranish K Patel, Katherine M Watson, Ivy H Gardner, Daniel O Herzig
Diseases of the Colon and Rectum. 2025-01-01
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.
Heinz-Josef Lenz, Tianshu Liu, Emerson Y Chen, Zsolt Horváth, Igor Bondarenko
JNCI Cancer Spectrum. 2024-11-23
Trends in complexity of single-agent and combination therapies for solid tumor cancers approved by the US Food and Drug Administration.
Emerson Y Chen, Manoj Rai, Yash Tadikonda, Preeyam Roy, Dakota W Nollner
The Oncologist. 2024-11-15

Lectures

Phase II study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020

Press Mentions

The FDA’s Accelerated Approval Process: When Drugs Are Cleared for Sale Based on Limited EvidenceOctober 18th, 2021
A New Look at the Dose-Response Relationship in Phase I Oncology TrialsMay 13th, 2020